| Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) (NCT04838444) | Valneva Austria GmbH | 2021-04-02 |
| Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults (NCT04786444) | Valneva Austria GmbH | 2021-02-22 |
| Phase 1 Study of SAR440894 vs Placebo (NCT04441905) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-10-14 |
| Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults (NCT04546724) | Valneva Austria GmbH | 2020-09-17 |
| Consequences of a Maternal-fetal Chikungunya Virus Infection (NCT04909411) | Centre Hospitalier Universitaire de la Réunion | 2020-01-13 |
| Yoga for Chronic Chikungunya (NCT04455919) | Centre Hospitalier Universitaire de la Guadeloupe | 2019-10-03 |
| Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) (NCT03807843) | Themis Bioscience GmbH | 2019-07-16 |
| Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) (NCT03635086) | Themis Bioscience GmbH | 2018-08-22 |
| Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults (NCT03483961) | Bavarian Nordic | 2018-04-18 |
| Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (NCT03631719) | Universidad de Antioquia | 2017-10-25 |
| Phase I Trial of Measles Vectored Chikungungya Vaccine (NCT03028441) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-05-30 |
| Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (NCT02861586) | Themis Bioscience GmbH | 2016-08-17 |
| Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults (NCT02562482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-18 |
| Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection (NCT02553369) | University Hospital Center of Martinique | 2015-02-01 |
| Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (NCT02230163) | Centre Hospitalier Universitaire de la Guadeloupe | 2014-09-01 |
| Chikungunya Virus Vaccine Trial in Healthy Adults (NCT01489358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |